Dutch health tech company Philips raises outlook as Q3 profit jumps
Dutch health technology company Philips on Monday raised its full-year outlook as it beat analyst expectations with a more than doubling of third-quarter core profit to 457 million euros ($483.3 mi...
What's in the Cards for Koninklijke Philips' (PHG) Q3 Earnings?
Koninklijke Philips' (PHG) third-quarter results are likely to reflect strength in the Diagnosis & Treatment and Connected Care segments amid macroeconomic challenges.
Philips (PHG) Aids Clinicians With New Monitoring Solution
Philips (PHG) launches Visual Patient Avatar to help anesthesiologists with situational awareness in operating rooms, boosting their clinical confidence.
Koninklijke Philips: Hold For Now
Exor recently entered Philips with a 15% equity stake (and optionality to arrive at 20%). PHG agrees to conduct additional testing and notes ongoing communication and cooperation with the FDA. Here...
Philips ADRs Slide as FDA Says It's Unsatisfied With Sleep Apnea Machine Recall
American depositary receipts (ADRs) of Koninklijke Philips (PHG) sank in early trading on Friday as the Food and Drug Administration (FDA) ruled the Netherlands-based health tech firm's handling of...
Philips stock tumbles after FDA says its unsatisfied with recall
Shares of Royal Philips (PHG) tumbled in early trading on Friday after the U.S. Food and Drug Administration said it was not satisfied with how the company handled a recall of its breathing device ...
Why Shares of Koninklijke Philips Are Falling on Friday
Philips said it would do the additional testing the FDA is requiring. The company recently settled some claims regarding the recalled products but faces other legal challenges.
Philips Stock Sinks Amid FDA Accusations
The shares of Koninklijke Philips NV (NYSE:PHG) are plummeting in premarket trading this morning, as the Dutch healthcare tech company comes under fire from the U.S. Food and Drug Administration (F...
Philips shares fall 8% after U.S. drug regulator deals fresh blow to sleep device recall
Shares of Dutch health tech company Philips fell on Friday after the U.S. drug regulator deemed its handling of a major product recall inadequate.
FDA says it is not satisfied with Philips breathing device recall
The U.S. Food and Drug Administration (FDA) remains unsatisfied with the status of a product recall by healthcare technology company Philips , the regulator said in an update.
Why Royal Philips (PHG) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Product Recall Nearly Finished, Philips CEO Says
Royal Philips NV CEO Roy Jakobs talks about the the consequences of recalling sleep apnea devices. He says the Dutch maker of medical gear has not put out a final figure on the cost of the recall, ...
'We are using more AI' in the healthcare industry, Philips CEO says
Philips CEO Roy Jakobs talks about his businesses priorities and the outlook moving forward.
Philips: A Healthcare Leader But A Very Risky Investment
Philips faces significant challenges and controversies, including the results of a forced recall of ventilators and respiratory devices, leading to financial provisions and damage to its brand repu...
CPAP maker Philips agrees to pay at least $479 million to users over recalled devices
CPAP sleep apnea machine maker Philips Respironics agreed to pay at least $479 million in a settlement over alleged health risks from toxic sound reducing foam, lawyers for the plaintiff announced ...
Related Companies